Baird analyst Andrew Wittmann raised the firm’s price target on Healthcare Services to $13 from $10 and keeps a Neutral rating on the shares. The firm said after a year of challenging earnings reports and systemic industry pressures, management’s pivoting “growth” commentary and better cash collections are positives.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HCSG: